Instrument Development of Screening Prediabetes Patients

This study has been terminated.
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT00308646
First received: March 29, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
  Purpose

It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection.


Condition
Prediabetic State

Study Type: Observational
Study Design: Allocation: Random Sample
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Instrument Development of Screening Prediabetes Patients

Resource links provided by NLM:


Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 3000
Study Start Date: October 2004
Estimated Study Completion Date: July 2005
Detailed Description:

During the past years, many efforts were put on the diagnosis and treatment of DM and its complications. It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection. As a first public health step, it is worthwhile to identify prediabetes people in community by screening program. Three thousand persons will be randomly selected from residents of Taichung city. All the participants will fulfill a structured questionnaire and 'Diabetes risk factor screening tool' which American Diabetes Association suggested in 2003. This project will estimate the prevalence of prediabetes in conventional hospital-base population as well as the validity of a screening questionnaire for prediabetes.

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Residents aged 40 and over of Taichung city, Taiwan in October, 2004.

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00308646

Sponsors and Collaborators
China Medical University Hospital
National Science Council, Taiwan
Investigators
Principal Investigator: Lin C Chieh, Professor School of Medicine, China Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00308646     History of Changes
Other Study ID Numbers: NSC93-2314-B-039-025
Study First Received: March 29, 2006
Last Updated: March 29, 2006
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Glucose Intolerance
Prediabetic State
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 31, 2014